Wang J - Search Results

1

Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1β in mice.

Cui K, Yan G, Xu C, Chen Y, Wang J, Zhou R, Bai L, Lian Z, Wei H, Sun R, Tian Z. Cui K, et al. Among authors: wang j. J Hepatol. 2015 Jun;62(6):1311-8. doi: 10.1016/j.jhep.2014.12.027. Epub 2015 Jan 10. J Hepatol. 2015. PMID: 25582105

2

CRACC-CRACC interaction between Kupffer and NK cells contributes to poly I:C/D-GalN induced hepatitis.

Li Y, Cao G, Zheng X, Wang J, Wei H, Tian Z, Sun R. Li Y, et al. Among authors: wang j. PLoS One. 2013 Sep 30;8(9):e76681. doi: 10.1371/journal.pone.0076681. eCollection 2013. PLoS One. 2013. PMID: 24098802 Free PMC article.

3

Nanoparticles encapsulating hepatitis B virus cytosine-phosphate-guanosine induce therapeutic immunity against HBV infection.

Lv S, Wang J, Dou S, Yang X, Ni X, Sun R, Tian Z, Wei H. Lv S, et al. Among authors: wang j. Hepatology. 2014 Feb;59(2):385-94. doi: 10.1002/hep.26654. Epub 2013 Dec 20. Hepatology. 2014. PMID: 23907803

4

Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells.

Sun R, Liu Y, Li SY, Shen S, Du XJ, Xu CF, Cao ZT, Bao Y, Zhu YH, Li YP, Yang XZ, Wang J. Sun R, et al. Among authors: wang j. Biomaterials. 2015 Jan;37:405-14. doi: 10.1016/j.biomaterials.2014.10.018. Epub 2014 Oct 23. Biomaterials. 2015. PMID: 25453968

5

Enhancement of lipopolysaccharide-induced nitric oxide and interleukin-6 production by PEGylated gold nanoparticles in RAW264.7 cells.

Liu Z, Li W, Wang F, Sun C, Wang L, Wang J, Sun F. Liu Z, et al. Among authors: wang f, wang l, wang j. Nanoscale. 2012 Nov 21;4(22):7135-42. doi: 10.1039/c2nr31355c. Nanoscale. 2012. PMID: 23070238

6

Sheddable ternary nanoparticles for tumor acidity-targeted siRNA delivery.

Yang XZ, Du JZ, Dou S, Mao CQ, Long HY, Wang J. Yang XZ, et al. Among authors: wang j. ACS Nano. 2012 Jan 24;6(1):771-81. doi: 10.1021/nn204240b. Epub 2011 Dec 9. ACS Nano. 2012. PMID: 22136582

7

Anti-Her2 single-chain antibody mediated DNMTs-siRNA delivery for targeted breast cancer therapy.

Dou S, Yao YD, Yang XZ, Sun TM, Mao CQ, Song EW, Wang J. Dou S, et al. Among authors: wang j. J Control Release. 2012 Aug 10;161(3):875-83. doi: 10.1016/j.jconrel.2012.05.015. Epub 2012 May 14. J Control Release. 2012. PMID: 22762887

8

N-acetylgalactosamine functionalized mixed micellar nanoparticles for targeted delivery of siRNA to liver.

Wang HX, Xiong MH, Wang YC, Zhu J, Wang J. Wang HX, et al. Among authors: wang j, wang yc. J Control Release. 2013 Mar 10;166(2):106-14. doi: 10.1016/j.jconrel.2012.12.017. Epub 2012 Dec 20. J Control Release. 2013. PMID: 23266452

9

ScFv-decorated PEG-PLA-based nanoparticles for enhanced siRNA delivery to Her2⁺ breast cancer.

Dou S, Yang XZ, Xiong MH, Sun CY, Yao YD, Zhu YH, Wang J. Dou S, et al. Among authors: wang j. Adv Healthc Mater. 2014 Nov;3(11):1792-803. doi: 10.1002/adhm.201400037. Epub 2014 Jun 20. Adv Healthc Mater. 2014. PMID: 24947820

10

Matrix metalloproteinase 2-responsive micelle for siRNA delivery.

Wang HX, Yang XZ, Sun CY, Mao CQ, Zhu YH, Wang J. Wang HX, et al. Among authors: wang j. Biomaterials. 2014 Aug;35(26):7622-34. doi: 10.1016/j.biomaterials.2014.05.050. Epub 2014 Jun 11. Biomaterials. 2014. PMID: 24929619

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219,833 results

Search Page

Filters